D-1145-2023 Class III Terminated

Recalled by Ascend Laboratories, LLC — Parsippany, NJ

FDA drug recall D-1145-2023 was initiated by Ascend Laboratories, LLC on Jul 18, 2023 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability. The recall status is terminated (terminated Feb 19, 2026). Affected quantity: 99,516 sachets.

Recall details

Product Type
Drugs
Report Date
Sep 13, 2023
Initiation Date
Jul 18, 2023
Termination Date
Feb 19, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
99,516 sachets

Product description

Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57

Reason for recall

Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.

Distribution pattern

The recall product was distributed nationwide.

Code information

Lot #22121970, 22122158, 22121971, 22122189, 22122190, 22122277, 22122278, Exp June 2024; 22122521, 22122522, 22122523, Exp July 2024; 22123328, 22123329, 22123330, Exp September 2024.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1145-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1145-2023. Report a data issue: hello@regdatalab.com.